FibroGen Inc (NAS:FGEN)
$ 1.19 0.01 (0.85%) Market Cap: 118.38 Mil Enterprise Value: 89.74 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 58/100

Q2 2022 FibroGen Inc Earnings Call Transcript

Aug 08, 2022 / 09:00PM GMT
Release Date Price: $14.6 (+0.62%)
Operator

Good day and thank you for standing by. Welcome to the FibroGen's Second Quarter 2022 Earnings Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Michael Tung. Please go ahead.

Michael Tung
FibroGen, Inc. - IR Executive

Thank you, Bella, and good afternoon, everyone. I'm Michael Tung, Vice President of Corporate Strategy and Investor Relations at FibroGen. Joining me on today's call are Enrique Conterno, our Chief Executive Officer; Dr. Mark Eisner, our Chief Medical Officer; Juan Graham, our Chief Financial Officer, Dr. John Hunter, our Chief Scientific Officer; Thane Wettig, our Chief Commercial Officer; and Chris Chung, our Senior Vice President of China Operations.

The format for today's call includes prepared remarks from Enrique and Juan, after which we will open up the call for Q&A. I would like to remind you that remarks made on today's call include forward-looking statements about FibroGen. Such statements may include, but

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot